{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:48:37Z","timestamp":1766087317567,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"\u201cLight of West China\u201d Program","award":["[2014]91 to Z.Z."],"award-info":[{"award-number":["[2014]91 to Z.Z."]}]},{"name":"CAS Strategic biological resources service network","award":["ZSTH-021"],"award-info":[{"award-number":["ZSTH-021"]}]},{"name":"the Strategic Priority Research Program of the Chinese Academy of Sciences","award":["XDA12030206"],"award-info":[{"award-number":["XDA12030206"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10822-018-0122-1","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T09:04:28Z","timestamp":1536051868000},"page":"901-915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Discovery of novel wee1 inhibitors via structure-based virtual screening and biological evaluation"],"prefix":"10.1007","volume":"32","author":[{"given":"Yaping","family":"Li","sequence":"first","affiliation":[]},{"given":"Yinglan","family":"Pu","sequence":"additional","affiliation":[]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Xingyong","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3576-2884","authenticated-orcid":false,"given":"Zhili","family":"Zuo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"3","key":"122_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/genetics\/96.3.627","volume":"96","author":"P Nurse","year":"1980","unstructured":"Nurse P, Thuriaux P (1980) Regulatory genes controlling mitosis in the fission yeast Schizosaccharomyces pombe. Genetics 96(3):627\u2013637","journal-title":"Genetics"},{"issue":"9","key":"122_CR2","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/j.1460-2075.1995.tb07180.x","volume":"14","author":"N Watanabe","year":"1995","unstructured":"Watanabe N, Broome M, Hunter T (1995) Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. Embo J 14(9):1878\u20131891","journal-title":"Embo J"},{"issue":"21","key":"122_CR3","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.18632\/oncotarget.2508","volume":"5","author":"JP Mak","year":"2014","unstructured":"Mak JP, Man WY, Ma HT, Poon RY (2014) Pharmacological targeting the ATR-CHK1-WEE1 axis involves balancing cell growth stimulation and apoptosis. Oncotarget 5(21):10546\u201310557. https:\/\/doi.org\/10.18632\/oncotarget.2508","journal-title":"Oncotarget"},{"issue":"4","key":"122_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1091\/mbc.6.4.371","volume":"6","author":"GJ Haese Den","year":"1995","unstructured":"Den Haese GJ, Walworth N, Carr AM, Gould KL (1995) The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2. Mol Biol Cell 6(4):371\u2013385. https:\/\/doi.org\/10.1091\/mbc.6.4.371","journal-title":"Mol Biol Cell"},{"issue":"6367","key":"122_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/356353a0","volume":"356","author":"R Rowley","year":"1992","unstructured":"Rowley R, Hudson J, Young PG (1992) The wee1 protein kinase is required for radiation-induced mitotic delay. Nature 356(6367):353\u2013355. https:\/\/doi.org\/10.1038\/356353a0","journal-title":"Nature"},{"issue":"13","key":"122_CR6","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1158\/1078-0432.ccr-10-2537","volume":"17","author":"PC Witt Hamer De","year":"2011","unstructured":"De Witt Hamer PC, Mir SE, Noske D, Van Noorden CJ, Wurdinger T (2011) WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe. Clin Cancer Res 17(13):4200\u20134207. https:\/\/doi.org\/10.1158\/1078-0432.ccr-10-2537","journal-title":"Clin Cancer Res"},{"issue":"1","key":"122_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1476-4598-8-34","volume":"8","author":"S Mizuarai","year":"2009","unstructured":"Mizuarai S, Yamanaka K, Itadani H, Arai T, Nishibata T, Hirai H, Kotani H (2009) Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor. Mol Cancer 8(1):34. https:\/\/doi.org\/10.1186\/1476-4598-8-34","journal-title":"Mol Cancer"},{"issue":"12","key":"122_CR8","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1158\/1535-7163.MCT-13-0424","volume":"12","author":"AA Linden Van","year":"2013","unstructured":"Van Linden AA, Baturin D, Ford JB, Fosmire SP, Gardner L, Korch C, Reigan P, Porter CC (2013) Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality. Mol Cancer Ther 12(12):2675\u20132684. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0424","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"122_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/1471-2407-14-430","volume":"14","author":"WN Pappano","year":"2014","unstructured":"Pappano WN, Qian Z, Tucker LA, Tse C, Wang J (2014) Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells. BMC Cancer 14(1):430. https:\/\/doi.org\/10.1186\/1471-2407-14-430","journal-title":"BMC Cancer"},{"key":"122_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1471-2407-6-292","volume":"6","author":"O Hashimoto","year":"2006","unstructured":"Hashimoto O, Shinkawa M, Torimura T, Nakamura T, Selvendiran K, Sakamoto M, Koga H, Ueno T, Sata M (2006) Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line. BMC Cancer 6:292. https:\/\/doi.org\/10.1186\/1471-2407-6-292","journal-title":"BMC Cancer"},{"issue":"17","key":"122_CR11","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1158\/1078-0432.ccr-11-0650","volume":"17","author":"KA Bridges","year":"2011","unstructured":"Bridges KA, Hirai H, Buser CA, Brooks C, Liu H, Buchholz TA, Molkentine JM, Mason KA, Meyn RE (2011) MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin Cancer Res 17(17):5638\u20135648. https:\/\/doi.org\/10.1158\/1078-0432.ccr-11-0650","journal-title":"Clin Cancer Res"},{"issue":"16","key":"122_CR12","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1021\/jm0512591","volume":"49","author":"BD Palmer","year":"2006","unstructured":"Palmer BD, Thompson AM, Booth RJ, Dobrusin EM, Kraker AJ, Lee HH, Lunney EA, Mitchell LH, Ortwine DF, Smaill JB, Swan LM, Denny WA (2006) 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution. J Med Chem 49(16):4896\u20134911. https:\/\/doi.org\/10.1021\/jm0512591","journal-title":"J Med Chem"},{"issue":"8","key":"122_CR13","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1158\/1078-0432.ccr-14-2588","volume":"21","author":"JL Pokorny","year":"2015","unstructured":"Pokorny JL, Calligaris D, Gupta SK, Iyekegbe DO Jr, Mueller D, Bakken KK, Carlson BL, Schroeder MA, Evans DL, Lou Z, Decker PA, Eckel-Passow JE, Pucci V, Ma B, Shumway SD, Elmquist WF, Agar NY, Sarkaria JN (2015) The efficacy of the wee1 inhibitor MK-1775 combined with temozolomide is limited by heterogeneous distribution across the blood-brain barrier in glioblastoma. Clin Cancer Res 21(8):1916\u20131924. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-2588","journal-title":"Clin Cancer Res"},{"issue":"9","key":"122_CR14","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1158\/1078-0432.ccr-10-2580","volume":"17","author":"NV Rajeshkumar","year":"2011","unstructured":"Rajeshkumar NV, De Oliveira E, Ottenhof N, Watters J, Brooks D, Demuth T, Shumway SD, Mizuarai S, Hirai H, Maitra A, Hidalgo M (2011) MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts. Clin Cancer Res 17(9):2799\u20132806. https:\/\/doi.org\/10.1158\/1078-0432.ccr-10-2580","journal-title":"Clin Cancer Res"},{"issue":"19","key":"122_CR15","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.4161\/cc.26062","volume":"12","author":"K Do","year":"2013","unstructured":"Do K, Doroshow JH, Kummar S (2013) Wee1 kinase as a target for cancer therapy. Cell Cycle 12(19):3159\u20133164. https:\/\/doi.org\/10.4161\/cc.26062","journal-title":"Cell Cycle"},{"issue":"1\u20132","key":"122_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/BF01718702","volume":"2","author":"M Hassan","year":"1996","unstructured":"Hassan M, Bielawski JP, Hempel JC, Waldman M (1996) Optimization and visualization of molecular diversity of combinatorial libraries. Mol Divers 2(1\u20132):64\u201374","journal-title":"Mol Divers"},{"issue":"1","key":"122_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1):3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"122_CR18","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"issue":"4","key":"122_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.str.2004.12.017","volume":"13","author":"CJ Squire","year":"2005","unstructured":"Squire CJ, Dickson JM, Ivanovic I, Baker EN (2005) Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation. Structure 13(4):541\u2013550. https:\/\/doi.org\/10.1016\/j.str.2004.12.017","journal-title":"Structure"},{"issue":"6","key":"122_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.ejmech.2007.07.016","volume":"43","author":"JB Smaill","year":"2008","unstructured":"Smaill JB, Baker EN, Booth RJ, Bridges AJ, Dickson JM, Dobrusin EM, Ivanovic I, Kraker AJ, Lee HH, Lunney EA, Ortwine DF, Palmer BD, Quin J 3rd, Squire CJ, Thompson AM, Denny WA (2008) Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases. Eur J Med Chem 43(6):1276\u20131296. https:\/\/doi.org\/10.1016\/j.ejmech.2007.07.016","journal-title":"Eur J Med Chem"},{"issue":"3","key":"122_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.bmcl.2007.12.046","volume":"18","author":"JB Smaill","year":"2008","unstructured":"Smaill JB, Lee HH, Palmer BD, Thompson AM, Squire CJ, Baker EN, Booth RJ, Kraker A, Hook K, Denny WA (2008) Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases. Bioorg Med Chem Lett 18(3):929\u2013933. https:\/\/doi.org\/10.1016\/j.bmcl.2007.12.046","journal-title":"Bioorg Med Chem Lett"},{"issue":"11\u201312","key":"122_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"SY Yang","year":"2010","unstructured":"Yang SY (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15(11\u201312):444\u2013450. https:\/\/doi.org\/10.1016\/j.drudis.2010.03.013","journal-title":"Drug Discov Today"},{"issue":"3","key":"122_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/ci950273r","volume":"36","author":"D Barnum","year":"1996","unstructured":"Barnum D, Greene J, Smellie A, Sprague P (1996) Identification of common functional configurations among molecules. J Chem Inf Comput Sci 36(3):563\u2013571. https:\/\/doi.org\/10.1021\/ci950273r","journal-title":"J Chem Inf Comput Sci"},{"issue":"6","key":"122_CR24","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.ejmech.2011.03.035","volume":"46","author":"S Thangapandian","year":"2011","unstructured":"Thangapandian S, John S, Sakkiah S, Lee KW (2011) Potential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches. Eur J Med Chem 46(6):2469\u20132476. https:\/\/doi.org\/10.1016\/j.ejmech.2011.03.035","journal-title":"Eur J Med Chem"},{"issue":"14","key":"122_CR25","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"issue":"7","key":"122_CR26","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53(7):2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"},{"issue":"14","key":"122_CR27","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/bioinformatics\/btr333","volume":"27","author":"D Lagorce","year":"2011","unstructured":"Lagorce D, Maupetit J, Baell J, Sperandio O, Tuffery P, Miteva MA, Galons H, Villoutreix BO (2011) The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections. Bioinformatics 27(14):2018\u20132020. https:\/\/doi.org\/10.1093\/bioinformatics\/btr333","journal-title":"Bioinformatics"},{"issue":"3","key":"122_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R by Cohen FE (1997) Development and validation of a genetic algorithm for flexible docking 11 edited. J Mol Biol 267(3):727\u2013748. https:\/\/doi.org\/10.1006\/jmbi.1996.0897","journal-title":"J Mol Biol"},{"issue":"6","key":"122_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/BF00124324","volume":"9","author":"G Jones","year":"1995","unstructured":"Jones G, Willett P, Glen RC (1995) A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J Comput Aided Mol Des 9(6):532\u2013549. https:\/\/doi.org\/10.1007\/BF00124324","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"122_CR30","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ejmech.2008.09.027","volume":"44","author":"K Wichapong","year":"2009","unstructured":"Wichapong K, Lindner M, Pianwanit S, Kokpol S, Sippl W (2009) Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors. Eur J Med Chem 44(4):1383\u20131395. https:\/\/doi.org\/10.1016\/j.ejmech.2008.09.027","journal-title":"Eur J Med Chem"},{"issue":"24","key":"122_CR31","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37(24):4130\u20134146. https:\/\/doi.org\/10.1021\/jm00050a010","journal-title":"J Med Chem"},{"issue":"1","key":"122_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0169-7439(87)80096-5","volume":"2","author":"R Manne","year":"1987","unstructured":"Manne R (1987) Analysis of two partial-least-squares algorithms for multivariate calibration. Chemometr Intell Lab Syst 2(1):187\u2013197. https:\/\/doi.org\/10.1016\/0169-7439(87)80096-5","journal-title":"Chemometr Intell Lab Syst"},{"issue":"3","key":"122_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/ja01318a036","volume":"56","author":"H Lineweaver","year":"1934","unstructured":"Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56(3):658\u2013666. https:\/\/doi.org\/10.1021\/ja01318a036","journal-title":"J Am Chem Soc"},{"issue":"7","key":"122_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3727\/095535491820873191","volume":"3","author":"AH Cory","year":"1991","unstructured":"Cory AH, Owen TC, Barltrop JA, Cory JG (1991) Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture. Cancer Commun 3(7):207\u2013212. https:\/\/doi.org\/10.3727\/095535491820873191","journal-title":"Cancer Commun"},{"issue":"11","key":"122_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0960-894X(01)81162-8","volume":"1","author":"JA Barltrop","year":"1991","unstructured":"Barltrop JA, Owen TC, Cory AH, Cory JG (1991) 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicato. Bioorg Med Chem Lett 1(11):611\u2013614","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"122_CR36","first-page":"184","volume":"3","author":"TL Riss","year":"1992","unstructured":"Riss TL, Moravec RA (1992) Comparison of MTT, XTT, and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays. Mol Biol Cell 3(1):184\u2013190","journal-title":"Mol Biol Cell"},{"issue":"3","key":"122_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccr.2010.08.011","volume":"18","author":"SE Mir","year":"2010","unstructured":"Mir SE, De Witt Hamer PC, Krawczyk PM, Balaj L, Claes A, Niers JM, Van Tilborg AA, Zwinderman AH, Geerts D, Kaspers GJ, Peter Vandertop W, Cloos J, Tannous BA, Wesseling P, Aten JA, Noske DP, Van Noorden CJ, Wurdinger T (2010) In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer cell 18(3):244\u2013257. https:\/\/doi.org\/10.1016\/j.ccr.2010.08.011","journal-title":"Cancer cell"},{"key":"122_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2407-11-156","volume":"11","author":"J PosthumaDeBoer","year":"2011","unstructured":"PosthumaDeBoer J, Wurdinger T, Graat HC, van Beusechem VW, Helder MN, van Royen BJ, Kaspers GJ (2011) WEE1 inhibition sensitizes osteosarcoma to radiotherapy. BMC Cancer 11:156. https:\/\/doi.org\/10.1186\/1471-2407-11-156","journal-title":"BMC Cancer"},{"issue":"2","key":"122_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/annonc\/mdh073","volume":"15","author":"T Yoshida","year":"2004","unstructured":"Yoshida T (2004) The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 15(2):252\u2013256. https:\/\/doi.org\/10.1093\/annonc\/mdh073","journal-title":"Ann Oncol"},{"issue":"3","key":"122_CR40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1053\/jhep.2003.50112","volume":"37","author":"T Masaki","year":"2003","unstructured":"Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, Uchida N, Miyauchi Y, Yoshiji H, Watanabe S, Omata M, Kuriyama S (2003) Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37(3):534\u2013543. https:\/\/doi.org\/10.1053\/jhep.2003.50112","journal-title":"Hepatology"},{"issue":"2A","key":"122_CR41","first-page":"1097","volume":"26","author":"CC Lin","year":"2006","unstructured":"Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST (2006) Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2\/M-phase of the cell cycle. Anticancer Res 26(2A):1097\u20131104","journal-title":"Anticancer Res"},{"issue":"16","key":"122_CR42","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Spoel Van Der","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26(16):1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291","journal-title":"J Comput Chem"},{"issue":"3","key":"122_CR43","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65(3):712\u2013725. https:\/\/doi.org\/10.1002\/prot.21123","journal-title":"Proteins"},{"issue":"9","key":"122_CR44","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25(9):1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"issue":"2","key":"122_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1021\/ci050481b","volume":"46","author":"AB Wagner","year":"2006","unstructured":"Wagner AB (2006) SciFinder Scholar 2006: an empirical analysis of research topic query processing. J Chem Inf Model 46(2):767\u2013774. https:\/\/doi.org\/10.1021\/ci050481b","journal-title":"J Chem Inf Model"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-018-0122-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-018-0122-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-018-0122-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T13:13:47Z","timestamp":1661951627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-018-0122-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["122"],"URL":"https:\/\/doi.org\/10.1007\/s10822-018-0122-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"3 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}